These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 22132113)
1. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113 [TBL] [Abstract][Full Text] [Related]
2. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease. Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress. Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429 [TBL] [Abstract][Full Text] [Related]
4. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice. Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127 [TBL] [Abstract][Full Text] [Related]
5. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage. Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839 [TBL] [Abstract][Full Text] [Related]
6. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice. Xu X; Song N; Wang R; Jiang H; Xie J Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576 [TBL] [Abstract][Full Text] [Related]
7. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260 [TBL] [Abstract][Full Text] [Related]
8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673 [TBL] [Abstract][Full Text] [Related]
10. In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease. Zuo T; Xie M; Yan M; Zhang Z; Tian T; Zhu Y; Wang L; Sun Y Cell Prolif; 2022 Apr; 55(4):e13213. PubMed ID: 35274781 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
12. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease. Yun HM; Choi DY; Oh KW; Hong JT Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021 [TBL] [Abstract][Full Text] [Related]
13. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease. Ahlers-Dannen KE; Spicer MM; Fisher RA Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009 [TBL] [Abstract][Full Text] [Related]
14. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516 [TBL] [Abstract][Full Text] [Related]
15. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease. Balke D; Tatenhorst L; Dambeck V; Ribas VT; Vahsen BF; Michel U; Bähr M; Lingor P Mol Neurobiol; 2020 Feb; 57(2):685-697. PubMed ID: 31446549 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. Crocker SJ; Smith PD; Jackson-Lewis V; Lamba WR; Hayley SP; Grimm E; Callaghan SM; Slack RS; Melloni E; Przedborski S; Robertson GS; Anisman H; Merali Z; Park DS J Neurosci; 2003 May; 23(10):4081-91. PubMed ID: 12764095 [TBL] [Abstract][Full Text] [Related]
17. Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease. Kim YM; Choi SY; Hwang O; Lee JY Mol Neurobiol; 2022 Nov; 59(11):6956-6970. PubMed ID: 36057709 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease. Kim SN; Kim ST; Doo AR; Park JY; Moon W; Chae Y; Yin CS; Lee H; Park HJ Int J Neurosci; 2011 Oct; 121(10):562-9. PubMed ID: 21770712 [TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease. Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786 [TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease. Rosa AI; Duarte-Silva S; Silva-Fernandes A; Nunes MJ; Carvalho AN; Rodrigues E; Gama MJ; Rodrigues CMP; Maciel P; Castro-Caldas M Mol Neurobiol; 2018 Dec; 55(12):9139-9155. PubMed ID: 29651747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]